In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Laboratorios Grin SA de CV

Division of Lupin Ltd.

Latest From Laboratorios Grin SA de CV

FTC Says Three Is Not Enough: Lupin Must Divest To Acquire Gavis, Novel

Merger would leave three companies selling antibiotic doxycycline, but Gavis must still transfer its product to G&W Laboratories as a condition of $850m acquisition.

BioPharmaceutical India

Latin America – El Dorado For Indian Drug Firms?

A highly fragmented market, low penetration and a proactive regulatory environment could help Indian drug firms make a serious bid for the Latin American market.

BioPharmaceutical India

Deals Shaping The Medical Industry, May 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced March through April 2014

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Pharmaceuticals
    • OTC, Consumer
  • Therapeutic Areas
  • Ophthalmic
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • Mexico
  • Parent & Subsidiaries
  • Lupin Ltd.
  • Senior Management
  • Victor Fregoso, Pres.
  • Contact Info
  • Laboratorios Grin SA de CV
    Phone: 5200 2300
    Rodríguez Saro No. 630
    Distrito Federal, 03100